CompoAtlas

Soin stop imperfection

Natural health product licensed in Canada

Licence holder
Yves Rocher Amerique Du Nord Inc.
NPN or DIN-HM
80023887
Status
Inactive licence
Licence date
22 February 2011
Revision date
Not provided
Form
Crème
Route of administration
Topique
Application type
Officinale

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Acide 2-hydroxybenzoïque

Source : Acide salicylique

0.5 %

Non-medicinal ingredients

Acide béhénique, Phénoxyéthanol, Gomme de xanthane, Sorbate de potassium, Alcool cétéarylique, Isohexadecane, Methyl Propanediol, Pectine hydrolysée, Diméthicone, EDTA de tétrasodium, Allantoïne, Hydroxyde de sodium, Glycérine, Ceteareth-33, Gluconate de zinc, Extrait de racine de Scutellaria baicalensis, Copolymère d'acrylate de sodium/Taurate d'acryloyldiméthyl sodium, Eau d'hamamélis, Poly(sorbate) 80, Butylène glycol, Dioxyde de silicium, Ethanol, Benzoate de sodium, Mangiférine, Parfum, jus d'aloès, Triglyceride Caprylique/caprique, Eau purifiée

PopulationAgeQuantity per servingFrequency
Sous-population S/ONot specifiedNot specifiedmaximum: 2 days

Uses authorised in Canada

Traite les boutons d'acné et facilite la guérison de la peau

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80023887

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line